Biocryst Pharmaceuticals Inc (BCRX)
Operating Cash Flow Growth
2039.89%
TTM · Period ending:
BCRX Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported2039.89%period ending
Latest reported2039.89%period ending
BCRX TTM Cash from Operations YoY % (-18.46% → 2039.89%)
Year-over-year change
High-resolution chart · PNG
BCRX operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -419.5802% | |
| -28,938.9181% | |
| 35.1502% | |
| -239.6% | |
| -38.1667% | |
| 100.6386% | |
| -16.6667% | |
| 95.5752% | |
| 89.0909% | |
| 56.701% | |
| 59.2233% | |
| -26.9663% | |
| -26.4368% | |
| -21.25% | |
| -51.4706% | |
| -30.8824% | |
| -38.0952% | |
| -21.2121% | |
| 11.6883% | |
| 10.5263% | |
| 18.1818% | |
| 16.4557% | |
| -18.4615% |